Neuropsychiatric Disease and Treatment: 20 Years on

Affiliations

Editorial

Roger M Pinder. Neuropsychiatr Dis Treat. 2025.

. 2025 Mar 1:21:463-464.

doi: 10.2147/NDT.S520367. eCollection 2025.

No abstract available

Conflict of interest statement

Dr Pinder is the Editor in Chief for Neuropsychiatric Disease and Treatment. The author report no other conflicts of interest in this work.

1. Pinder RM. Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant? Neuropsychiatr Dis Treat. 2005;1(1):3–7. doi:10.2147/nedt.1.1.3.52293 - DOI - PMC - PubMed
1. Correll CU, Schooler NR. Negative symptoms in schizophrenia: a review and clinical guide for recognition, assessment, and treatment. Neuropsychiatr Dis Treat. 2020;16:519–534. doi:10.2147/NDT.S225643 - DOI - PMC - PubMed
1. Alhola P, Polo-Kantola P. Sleep deprivation: impact on cognitive performance. Neuropsychiatr Dis Treat. 2007;3(5):553–567. - PMC - PubMed
1. Huang Y, Sh X, Li Z, et al. Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder. Neuropsychiatr Dis Treat. 2018;14:3329–3337. doi:10.2147/NDT.S188340 - DOI - PMC - PubMed
1. Schlarb AA, Friedrich A, Classen M. Sleep problems in university students - an intervention. Neuropsychiatr Dis Treat. 2017;13:1989–2001. doi:10.2147/NDT.S142067 - DOI - PMC - PubMed